Skip to main content

BrightSpire Capital, Inc.

For the period ended Dec 31, 2025. Filed Feb 18, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 18, 2026

BRSP$3.37+0.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

16. Earnings Per Share F-

  1. Earnings Per Share

The Company’s net loss and weighted average shares outstanding for the years ended December 31, 2025, 2024 and 2023 consist of the following (dollars in thousands, except per share data):

Year Ended December 31,
202520242023
Net loss$(38,768)$(135,517)$(15,619)
Net income (loss) attributable to noncontrolling interests:
Investment Entities7,6203,53870
Net loss attributable to BrightSpire Capital, Inc. common stockholders$(31,148)$(131,979)$(15,549)
Numerator:
Dividends allocated to participating securities (non-vested shares)$(1,857)$(1,928)$—
Net income (loss) attributable to common stockholders$(33,005)$(133,907)$(15,549)
Denominator:
Weighted average shares outstanding - basic(1)126,883127,441127,060
Weighted average shares outstanding - diluted(2)126,883127,441127,060
Net loss per common share - basic$(0.26)$(1.05)$(0.12)
Net loss per common share - diluted$(0.26)$(1.05)$(0.12)

(1)The outstanding shares used to calculate the weighted average basic shares outstanding exclude 2,865,399,2,742,917 and 2,787,807 of restricted stock awards as of December 31, 2025, December 31, 2024 and December 31, 2023, net of forfeitures, respectively, as those shares were issued but were not vested and therefore, not considered outstanding for purposes of computing basic net income (loss) per common share.

(2)The calculation of diluted earnings per share excludes the effect of weighted average unvested non-participating restricted shares of 2,872,241,2,709,429 and 2,734,075 for the years ended December 31, 2025, December 31, 2024 and December 31, 2023, respectively, as the effect would be antidilutive.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.